当前位置:首页 - 行情中心 - 迈克生物(300463) - 财务分析

迈克生物

(300463)

  

流通市值:63.06亿  总市值:77.97亿
流通股本:4.95亿   总股本:6.12亿

迈克生物(300463)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.24亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益671248.29万元,未分配利润396086.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产812449.87万元,负债141201.58万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入616,367,154.022,895,769,512.022,115,080,245.61,380,723,264.24
营业总成本483,286,866.62,506,578,260.551,749,690,942.21,148,444,030.53
营业利润136,445,234.39331,144,756.3306,046,164.47188,407,548.85
利润总额135,983,582.27305,368,973.69295,604,666.88182,507,232.46
净利润124,243,826.11304,679,076.7268,032,171.76171,726,883.6
其他综合收益-363,649.36-8,400,942.55-16,909,056.6-9,123,716.24
综合收益总额123,880,176.75296,278,134.15251,123,115.16162,603,167.36
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计4,121,289,063.214,222,217,919.774,474,641,293.964,597,117,752.6
非流动资产合计4,003,209,669.233,897,031,388.163,758,057,433.973,638,077,038.83
资产总计8,124,498,732.448,119,249,307.938,232,698,727.938,235,194,791.43
流动负债合计1,082,471,807.861,120,605,110.521,206,464,832.341,065,852,775.76
非流动负债合计329,543,976.11387,182,176.87458,656,522.3689,839,090.18
负债合计1,412,015,783.971,507,787,287.391,665,121,354.641,755,691,865.94
归属于母公司股东权益合计6,482,044,621.066,384,825,270.346,333,751,198.946,247,695,812.3
股东权益合计6,712,482,948.476,611,462,020.546,567,577,373.296,479,502,925.49
负债和股东权益合计8,124,498,732.448,119,249,307.938,232,698,727.938,235,194,791.43
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计765,844,742.923,553,671,358.822,731,072,342.461,830,638,095.39
经营活动现金流出小计760,960,455.262,652,161,236.832,113,952,205.791,420,912,840.44
经营活动产生的现金流量净额4,884,287.66901,510,121.99617,120,136.67409,725,254.95
投资活动现金流入小计311,967,100.012,153,949,590.581,721,708,370.671,254,875,303.07
投资活动现金流出小计351,428,278.872,656,992,535.432,025,386,606.31,395,974,228.17
投资活动产生的现金流量净额-39,461,178.86-503,042,944.85-303,678,235.63-141,098,925.1
筹资活动现金流入小计134,152,157.14608,746,870.84508,852,525.04498,063,964.89
筹资活动现金流出小计117,986,131.64761,497,452.58641,941,752.17500,359,976.04
筹资活动产生的现金流量净额16,166,025.5-152,750,581.74-133,089,227.13-2,296,011.15
汇率变动对现金及现金等价物的影响167,453.921,352,665.952,347,652.741,413,751.28
现金及现金等价物净增加额-18,243,411.78247,069,261.35182,700,326.65267,744,069.98
期末现金及现金等价物余额793,118,882.65811,362,294.43746,993,359.73832,037,103.06
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华泰证券代雯,高鹏,杨昌源0.710.881.082024-04-25
TOP↑